Skip to content

Does Vigabatrin Make You Tired? Understanding the Causes, Risks, and Management

4 min read

In controlled clinical trials, up to 40% of adults taking the antiepileptic drug vigabatrin reported experiencing fatigue, a side effect that can significantly impact daily life. This drowsiness and tiredness, also known as somnolence, is a well-documented side effect of the medication.

Quick Summary

Vigabatrin frequently causes fatigue and sleepiness by increasing the brain's inhibitory neurotransmitter, GABA. Managing symptoms involves strategic dosing, avoiding other sedatives, and discussing persistent tiredness with a healthcare provider.

Key Points

  • Fatigue is a Common Side Effect: Studies show that fatigue and sleepiness (somnolence) are reported by a significant percentage of patients taking vigabatrin, affecting up to 40% of adults in some trials.

  • Caused by Increased GABA: The medication's mechanism of increasing the inhibitory neurotransmitter GABA in the brain can cause general central nervous system depression, leading to tiredness and drowsiness.

  • Dose-Dependent Effect: The severity of fatigue can be dose-dependent, with higher doses potentially increasing the risk.

  • Management Strategies Exist: Ways to manage fatigue include adjusting dose timing (e.g., evening dosing), avoiding other sedatives, and improving sleep habits.

  • Requires Caution for Driving: Due to the risk of sleepiness, patients should not drive or operate heavy machinery until they know how the medication affects them.

  • Don't Stop Abruptly: Never stop taking vigabatrin suddenly, as abrupt discontinuation can lead to worsening seizures.

  • Regular Medical Consultations are Crucial: Regular communication with a healthcare provider is essential to manage side effects, adjust treatment, and monitor for more serious risks like vision loss.

In This Article

Vigabatrin: An Overview

Vigabatrin is a prescription antiepileptic medication primarily used to treat infantile spasms in infants and refractory complex partial seizures in adults and children who have not responded adequately to other treatments. The brand name for vigabatrin is Sabril. The drug works by increasing the levels of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain, thereby reducing the likelihood of seizures. However, this same mechanism of action can also lead to central nervous system (CNS) depression, which causes significant side effects, including tiredness.

The Direct Link Between Vigabatrin and Fatigue

Clinical data confirms that fatigue and somnolence (drowsiness) are among the most common adverse reactions reported by patients taking vigabatrin. The FDA prescribing information, based on pooled data from controlled trials, highlights the prevalence of these side effects.

Fatigue and Somnolence in Clinical Trials

  • Adults: In two U.S. clinical trials for refractory complex partial seizures, 28% of patients taking vigabatrin reported fatigue compared to 15% of those on placebo. In the same studies, 24% of vigabatrin patients experienced somnolence versus 10% of the placebo group. Higher doses were also linked to higher rates of fatigue, with up to 40% of patients on the highest dose reporting it.
  • Children: Data from pediatric clinical trials showed that 10% of vigabatrin patients experienced fatigue compared to 7% of those on placebo. Somnolence was reported in 6% of vigabatrin patients versus 5% in the placebo group.

The onset of these symptoms is often dose-dependent, and the risk can be higher when taken with other medications that cause drowsiness, such as benzodiazepines or muscle relaxants.

How Vigabatrin's Mechanism Causes Sleepiness

Vigabatrin acts as a "suicide inhibitor" of GABA transaminase, the enzyme responsible for breaking down GABA. By irreversibly blocking this enzyme, vigabatrin causes a buildup of GABA in the brain. GABA's primary function is to reduce neuronal excitability. While this is therapeutic for controlling seizures, the overall effect can be a general slowing of CNS activity, which is perceived as fatigue and sleepiness. The biological effects of vigabatrin can also outlast its presence in the body, which means the fatigue may persist even if plasma drug levels drop.

Comparing Vigabatrin's Side Effects to Other AEDs

Vigabatrin's side effect profile is distinct from other antiepileptic drugs (AEDs). While many AEDs can cause fatigue, vigabatrin carries a unique risk of irreversible vision loss that necessitates a special restricted distribution program and regular visual monitoring.

Feature Vigabatrin (Sabril) Carbamazepine (Tegretol) Valproic Acid (Depakote)
Fatigue/Somnolence Very common, reported in up to 40% of adults Common, often improves over time Common, dose-dependent
Primary Mechanism Irreversible inhibitor of GABA-T, increases brain GABA Blocks sodium channels to reduce nerve impulses Increases GABA, modulates sodium channels, blocks calcium channels
Serious Risks Irreversible peripheral vision loss, behavioral changes Agranulocytosis, aplastic anemia, serious skin reactions (SJS/TEN) Hepatotoxicity, pancreatitis, neural tube defects (pregnancy)
Cognitive Effects May have fewer cognitive side effects than carbamazepine Can cause cognitive impairment, including memory issues Can cause cognitive impairment
Other Common Side Effects Dizziness, tremor, weight gain, blurred vision, behavioral changes Dizziness, nausea, unsteadiness, rash, weight gain Nausea, tremor, hair loss, weight gain, abdominal pain

Managing Fatigue and Drowsiness from Vigabatrin

If you experience significant tiredness from vigabatrin, there are strategies to help manage the symptoms. It is crucial to work closely with your healthcare provider and never stop the medication suddenly, as this could worsen your seizures.

Here are some management strategies:

  • Timing the Dose: Taking your dose in the evening may help reduce daytime sleepiness. Your doctor might suggest adjusting the timing of your medication to minimize the impact on your daily routine.
  • Dose Adjustment: If fatigue is severe and persistent, your healthcare provider may consider lowering the dose. As clinical data shows, fatigue can be dose-dependent. Any adjustment must be made under medical supervision.
  • Avoid Other Sedatives: Be cautious with combining vigabatrin with other medications that cause drowsiness, including over-the-counter sleep aids, benzodiazepines, or muscle relaxants, as this can worsen the effect.
  • Prioritize Sleep Hygiene: Maintaining a regular sleep schedule, creating a restful sleep environment, and ensuring you get adequate hours of sleep can help counteract the medication's effects.
  • Lifestyle Adjustments: Regular, light exercise (with your doctor's approval), a healthy diet, and staying hydrated can support overall energy levels and help combat fatigue.
  • Do Not Drive: Vigabatrin affects everyone differently. Until you are familiar with how the medication affects your alertness, do not drive, operate heavy machinery, or perform any other hazardous tasks.

When to Talk to Your Doctor

It is important to communicate with your healthcare provider about any side effects you experience, especially fatigue. Inform them if you notice any changes in your mood, behavior, or energy levels. Also, report any new or worsening depression, anxiety, or suicidal thoughts, as vigabatrin has been associated with these. Immediate consultation is also necessary if you notice any changes in your vision, including blurred vision or a narrowing of your field of vision.

Conclusion

Yes, vigabatrin can cause significant fatigue and drowsiness, which are common and well-documented side effects of the medication. This occurs because vigabatrin increases the concentration of the inhibitory neurotransmitter GABA in the brain. While this is effective for seizure control, it can lead to generalized central nervous system depression. Managing this side effect involves a combination of adjusting dose timing, avoiding other sedating drugs, and adopting good sleep hygiene. It is critical for patients to work closely with their healthcare team to manage fatigue while addressing the potentially more serious side effects, such as irreversible vision loss. As with all medications, the goal is to find a balance where the therapeutic benefits outweigh the risks and side effects, ensuring the best possible quality of life.

Frequently Asked Questions

Vigabatrin causes tiredness by increasing the amount of GABA in the brain. GABA is a neurotransmitter that has an inhibitory, or calming, effect on the central nervous system. While this helps control seizures, the increased GABA can lead to feelings of sleepiness and fatigue.

Fatigue and sleepiness are very common side effects. Clinical trial data showed that up to 40% of adults taking vigabatrin reported fatigue, and up to 24% experienced somnolence, a formal term for drowsiness.

Yes, you can talk to your doctor about adjusting your dose or taking your medication at a different time, such as in the evening, to reduce daytime sleepiness. Ensuring good sleep hygiene and avoiding other sedating substances can also help.

No, you should not drive or operate heavy machinery until you are certain how vigabatrin affects your alertness. The medication can cause significant drowsiness and tiredness that can impair your ability to perform these tasks safely.

If you experience severe or persistent fatigue, contact your healthcare provider. They can evaluate your symptoms, consider adjusting your dosage, or explore alternative treatment options.

Some people may develop a tolerance to the sedative effects of vigabatrin over time, leading to less noticeable fatigue. However, this is not the case for everyone, and the effect can persist throughout treatment.

Yes, taking other central nervous system depressants, such as benzodiazepines, certain antidepressants, or muscle relaxants, can increase the sedative effects of vigabatrin.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.